The DOI matches its Crossref record.
Association between glycaemic control and common infections in people with Type 2 diabetes: a cohort study
Abstract
Aim: To investigate the impact of glycaemic control on infection incidence in people with Type 2 diabetes. Methods: We compared infection rates during 2014 in people with Type 2 diabetes and people without diabetes in a large primary care cohort in the UK (the Royal College of General Practitioners Research and Surveillance Centre database). We performed multilevel logistic regression to investigate the impact of Type 2 diabetes on presentation with infection, and the effect of glycaemic control on presentation with upper respiratory tract infections, bronchitis, influenza‐like illness, pneumonia, intestinal infectious diseases, herpes simplex, skin and soft tissue infections, urinary tract infections, and genital and perineal infections. People with Type 2 diabetes were stratified by good [HbA 1c < 53 mmol/mol (< 7%)], moderate [HbA 1c 53–69 mmol/mol (7–8.5%)] and poor [HbA 1c > 69 mmol/mol (> 8.5%)] glycaemic control using their most recent HbA 1c concentration. Infection incidence was adjusted for important sociodemographic factors and patient comorbidities. Results: We identified 34 278 people with Type 2 diabetes and 613 052 people without diabetes for comparison. The incidence of infections was higher in people with Type 2 diabetes for all infections except herpes simplex. Worsening glycaemic control was associated with increased incidence of bronchitis, pneumonia, skin and soft tissue infections, urinary tract infections, and genital and perineal infections, but not with upper respiratory tract infections, influenza‐like illness, intestinal infectious diseases or herpes simplex. Conclusions: Almost all infections analysed were more common in people with Type 2 diabetes. Infections that are most commonly of bacterial, fungal or yeast origin were more frequent in people with worse glycaemic control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, only people with diabetes that have poor glycemic control [HB1Ac (glycated hemoglobin) > 8.5] are at a heightened risk for developing severe MRSA SSTIs, suggesting that sustained hyperglycemia is a driving force in infection susceptibility (32).”
From Lack of nutritional immunity in diabetic skin infections promotes Staphylococcus aureus virulence (2020) · cites this paper as [32]
In the citing paper
“Moreover, only people with diabetes that have poor glycemic control [HB1Ac (glycated hemoglobin) > 8.5] are at a heightened risk for developing severe MRSA SSTIs, suggesting that sustained hyperglycemia is a driving force in infection susceptibility (32).”
From Lack of nutritional immunity in diabetic skin infections promotes Staphylococcus aureus virulence (2020) · cites this paper as [32]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 27
- 10.1056/NEJM199912163412507 · DOI · Paper page
- 10.1677/joe.1.06438 · DOI · Paper page
- 10.1016/j.amjms.2015.11.011 · DOI · Paper page
- Bader MS, 2014, Management of hospitalized patients with diabetic foot infections, Hosp Pract 1995, 42, 111
- 10.1016/j.jdiacomp.2012.06.008 · DOI · Paper page
- 10.1016/j.ecl.2013.08.002 · DOI
- 10.2337/dc14-2820 · DOI
- 10.2337/diacare.24.6.1044 · DOI · Paper page
- 10.1007/s00125-006-0570-3 · DOI · Paper page
- 10.1016/j.jdiacomp.2012.06.012 · DOI
- 10.1016/S2213-8587(15)00379-4 · DOI · Paper page
- Fleming DM, 1999, Weekly returns service of the Royal College of General Practitioners, Commun Dis Public Health, 2, 96
- 10.1023/A:1007525402861 · DOI
- 10.1136/thorax.55.8.662 · DOI
- 10.1016/j.jbi.2014.07.016 · DOI
- World Health Organisation, 2006, Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia
- World Health Organisation, 2011, Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus
- 10.1093/infdis/jis206 · DOI · Paper page
- 10.1093/cid/cis028 · DOI
- 10.1155/2014/762051 · doi:10.1155/2014/762051
- 10.1016/S0924-8579(03)00234-6 · DOI · Paper page
- 10.1086/431587 · DOI · Paper page
- 10.2337/diacare.26.2.510 · DOI · Paper page
- 10.1093/eurpub/14.1.10 · DOI
- 10.7547/0003-0538-104.4.320 · DOI
- 10.1093/fampra/cmi106 · DOI · Paper page
- 10.1136/bmjopen-2016-011092 · DOI · Paper page
Cited by
Carey, I. M., Critchley, J. A., DeWilde, S., Harris, T., Hosking, F. J., & Cook, D. G. (2018) · Diabetes Care · doi:10.2337/dc17-2131 · Cited by 604
Critchley, J. A., Carey, I. M., Harris, T., DeWilde, S., Hosking, F. J., & Cook, D. G. (2018) · Diabetes Care · doi:10.2337/dc18-0287 · Cited by 391
Diabetes, infection risk and COVID-19
Erener, S. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101044 · Cited by 351
Lack of nutritional immunity in diabetic skin infections promotes Staphylococcus aureus virulence
Thurlow, L. R., Stephens, A. C., Hurley, K. E., & Richardson, A. R. (2020) · Science Advances · doi:10.1126/sciadv.abc5569 · Cited by 116
Lee, S., Ock, M., Kim, H., & Kim, H. (2020) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2450 · Cited by 13
Risk of infection in older adults with type 2 diabetes with relaxed glycemic control
Lipska, K. J., Gilliam, L. K., Lee, C., Liu, J. Y., Liu, V. X., Moffet, H. H., Parker, M. M., Zapata, H., & Karter, A. J. (2024) · Diabetes Care · doi:10.2337/dc24-1612 · Cited by 7
Metadata
- Authors
- Hine, J. L., de Lusignan, S., Burleigh, D., Pathirannehelage, S., McGovern, A., Gatenby, P., Jones, S., Jiang, D., Williams, J., Elliot, A. J., Smith, G. E., Brownrigg, J., Hinchliffe, R., & Munro, N.
- Affiliations
- Section of Clinical Medicine and Ageing University of Surrey Guildford
- Eli Lilly and Company Lilly Corporate Center Indianapolis IN USA
- Public Health England Birmingham UK
- St George's Vascular Institute Division of Cardiovascular Sciences St George's University of London London UK
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2016-09-22
- Volume
- 34
- Issue
- 4
- Pages
- 551-557
- ISSN
- 0742-3071
- 1464-5491
- Cited by
- 101
- References
- 0
- Language
- en
- Funders
- Royal College of General Practitioners
- University of Surrey
- Eli Lilly and Company
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.